P-305. No Clinically Significant Drug–Drug Interactions with Co-administration of Feminizing or Masculinizing Hormone Therapy and Twice-yearly Lenacapavir PrEP in Gender-Diverse Persons
P-305. 在性别多元人群中,同时服用雌激素或雄性激素疗法和每年两次的来那卡帕韦PrEP,未发现具有临床意义的药物相互作用
期刊:BMC Medical Imaging
影响因子:3.2
doi:10.1186/s12880-026-02374-4
Zhang, Zimin; Zhang, Haiyang; Song, Xuefei; Song, Yang; Zhou, Huifang; Zhu, Ling; Tao, Xiaofeng; Jiang, Mengda; Blumenthal, Jill; Acevedo-Quinones, Maribel; Phanuphak, Nittaya; Hinojosa, Juan Carlos; Lama, Javier R; Cespedes, Michelle S; Ndlovu, Nkosiphile; Brites, Carlos; Puryear, Sarah B; Brown, Lillian B; Carter, Christoph C; Arora, Priyanka; Imperial, Marjorie Z; Etchevers, Kim; Singh, Renu; Wong, Pamela; Van Gerwen, Olivia T